{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:40:28Z","timestamp":1773124828226,"version":"3.50.1"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.phrs.2020.104866","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:23:50Z","timestamp":1588785830000},"page":"104866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The CoV-2 outbreak: how hematologists could help to fight Covid-19"],"prefix":"10.1016","volume":"157","author":[{"given":"Sara","family":"Galimberti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Barat\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Buda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Fazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Baglietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersilia","family":"Lucenteforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.phrs.2020.104866_bib0005","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.11.2000230","article-title":"Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, 2020","volume":"25","author":"Nicastri","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.phrs.2020.104866_bib0010","doi-asserted-by":"crossref","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","author":"Lauer","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2020.104866_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","author":"Young","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.phrs.2020.104866_bib0020","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures","author":"Wang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.phrs.2020.104866_bib0025","doi-asserted-by":"crossref","unstructured":"COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention. Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea. Osong Public Health Res Perspect. 11(1) (2020) 8-14. doi: 10.24171\/j.phrp.2020.11.1.03.","DOI":"10.24171\/j.phrp.2020.11.1.03"},{"key":"10.1016\/j.phrs.2020.104866_bib0030","article-title":"Novel coronavirus (COVID-19) pneumonia with Hemoptysis as the initial symptom: CT and clinical features","volume":"2020","author":"Shi","year":"2019","journal-title":"Korean J. Radiol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","article-title":"COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?","volume":"38","author":"Sarzi-Puttini","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0040","article-title":"The trial of chloroquine in the treatment of corona virus disease 2019 (COVID-19) and its research progress in forensic toxicology","volume":"36","author":"Duan","year":"2020","journal-title":"Fa Yi Xue Za Zhi"},{"key":"10.1016\/j.phrs.2020.104866_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"17","key":"10.1016\/j.phrs.2020.104866_bib0050","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","article-title":"Tocilizumab: a review in rheumatoid arthritis","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2020.104866_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/DDDT.S150580","article-title":"Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection","volume":"13","author":"Biggioggero","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.15644","article-title":"Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy","volume":"183","author":"Hay","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome","author":"Kotch","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55563\/clinexprheumatol\/r3k9l6","article-title":"COVID-19: the new challenge for rheumatologists","volume":"38","author":"Ferro","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0075","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229708","article-title":"High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant","volume":"12","author":"Lind-Holst","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"7","key":"10.1016\/j.phrs.2020.104866_bib0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-018-0908-4","article-title":"Baricitinib: a review in rheumatoid arthritis","volume":"78","author":"Al-Salama","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2020.104866_bib0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/PPA.S233993","article-title":"Comparison of real-world treatment patterns among psoriasis patients treated with ixekizumab or adalimumab","volume":"14","author":"Blauvelt","year":"2020","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.phrs.2020.104866_bib0090","article-title":"Serum KL-6 elevation in a uveitis patient with Beh\u00e7et\u2019s disease treated with adalimumab","volume":"18","author":"Ono","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.phrs.2020.104866_bib0095","doi-asserted-by":"crossref","DOI":"10.2217\/imt-2020-0067","article-title":"Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0100","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21873\/anticanres.11483","article-title":"Tabbara I. Acute graft versus host disease: a comprehensive review","volume":"37","author":"Nassereddine","year":"2017","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41409-018-0224-3","article-title":"Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients","volume":"54","author":"Kerep","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.phrs.2020.104866_bib0110","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1172\/JCI90593","article-title":"Cytokine mediators of chronic graft-versus-host disease","volume":"127","author":"MacDonald","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.phrs.2020.104866_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.humimm.2019.03.003","article-title":"B cells in chronic graft-versus-host disease","volume":"80","author":"McManigle","year":"2019","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.phrs.2020.104866_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.phrs.2020.104866_bib0125","first-page":"459","article-title":"The incidence of macrophage activation syndrome in children with rheumatic disorders","volume":"63","author":"Moradinejad","year":"2011","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.phrs.2020.104866_bib0130","article-title":"Adult haemophagocytic lymphohistiocytosis: a Review","author":"Yildiz","year":"2020","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0140","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21873\/anticanres.11483","article-title":"Tabbara I. Acute graft versus host disease: a comprehensive review","volume":"37","author":"Nassereddine","year":"2017","journal-title":"Anticancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2020.104866_bib0145","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1182\/blood-2018-04-785899","article-title":"How I treat refractory chronic graft-versus-host disease","volume":"133","author":"Sarantopoulos","year":"2019","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00277-020-03968-w","article-title":"IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"99","author":"Kattner","year":"2020","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bmt.1705725","article-title":"Treatment of refractory chronic GVHD with rituximab: a GITMO study","volume":"40","author":"Zaja","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.phrs.2020.104866_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2009.04.003","article-title":"Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis","volume":"15","author":"Kharfan-Dabaja","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.phrs.2020.104866_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-020-0855-z","article-title":"Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab","author":"Bacigalupo","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/15548627.2017.1402992","article-title":"Autophagy balances inflammation in innate immunity","volume":"14","author":"Deretic","year":"2018","journal-title":"Autophagy."},{"key":"10.1016\/j.phrs.2020.104866_bib0180","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications","author":"Drucker","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2020.104866_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: Can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"21","key":"10.1016\/j.phrs.2020.104866_bib0190","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0195","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.20020873","article-title":"Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response","volume":"196","author":"Ernst","year":"2002","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.phrs.2020.104866_bib0200","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbmt.2019.06.023","article-title":"Ibrutinib for chronic graft-versus-Host disease after failure of prior therapy: 1-Year update of a phase 1b\/2 study","volume":"25","author":"Waller","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.phrs.2020.104866_bib0205","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-020-02448-y","article-title":"FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease","author":"King-Kallimanis","year":"2020","journal-title":"Qual. Life Res."},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid Cancer","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phrs.2020.104866_bib0215","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020006288","article-title":"The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients","author":"Treon","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-017-0527-7","article-title":"Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses","volume":"10","author":"Verstovsek","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood.2019000761","article-title":"Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis","volume":"134","author":"Albeituni","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2020.104866_bib0230","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020004823","article-title":"Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label, phase 2 trial","author":"Jagasia","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.phrs.2020.104866_bib0235","first-page":"1","article-title":"Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis","author":"Hui","year":"2020","journal-title":"Expert Rev. Hematol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104866_bib0240","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2020.104866_bib0245","first-page":"1","article-title":"Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis","author":"Hui","year":"2020","journal-title":"Expert Rev. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2013.235","article-title":"Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis","volume":"28","author":"Caocci","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2020.104866_bib0255","article-title":"Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: case series and literature review","author":"Khalid","year":"2020","journal-title":"Hematol. Stem Cell Ther."},{"key":"10.1016\/j.phrs.2020.104866_bib0260","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204950","article-title":"Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy","author":"Lee","year":"2014","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11864-013-0234-8","article-title":"Chronic myeloid leukemia: overview of new agents and comparative analysis","volume":"14","author":"Jain","year":"2013","journal-title":"Curr. Treat. Options Oncol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0270","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3324\/haematol.2018.205054","article-title":"Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice","volume":"20104","author":"Fava","year":"2019","journal-title":"Haematologica."},{"issue":"11","key":"10.1016\/j.phrs.2020.104866_bib0275","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1002\/cam4.2371","article-title":"Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission","volume":"8","author":"Dumas","year":"2019","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.phrs.2020.104866_bib0280","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.exphem.2015.08.004","article-title":"Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients","volume":"43","author":"Caocci","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.phrs.2020.104866_bib0285","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fimmu.2017.00469","article-title":"Immune effector recovery in chronic myeloid leukemia and treatment-free remission","volume":"8","author":"Hughes","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2020.104866_bib0290","article-title":"The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease","author":"Alsuliman","year":"2019","journal-title":"Curr. Res. Transl. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0295","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2009-02-204156","article-title":"Imatinib for refractory chronic graft-versus-host disease with fibrotic features","volume":"114","author":"Olivieri","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3325\/cmj.2016.57.247","article-title":"Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease","volume":"57","author":"S\u00e1nchez-Ortega","year":"2016","journal-title":"Croat. Med. J."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00277-017-3144-1","article-title":"Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series","volume":"97","author":"Iurlo","year":"2018","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0310","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200705-715CR","article-title":"Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series","volume":"176","author":"Bergeron","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0315","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.2008.07108.x","article-title":"Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis","volume":"141","author":"de Lavallade","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104866_bib0320","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/cncr.32627","article-title":"Long-term results of frontline dasatinib in chronic myeloid leukemia","volume":"126","author":"Maiti","year":"2020","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.phrs.2020.104866_bib0325","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-Year study results of DASISION: the dasatinib versus imatinib study in treatment-na\u00efve chronic myeloid leukemia patients trial","volume":"34","author":"Cortes","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104866_bib0330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-319-91439-8_4","article-title":"Wolf D. Bosutinib: a potent second-generation tyrosine kinase inhibitor","volume":"212","author":"Isfort","year":"2018","journal-title":"Recent Results Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2020.104866_bib0335","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00277-019-03802-y","article-title":"Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy","volume":"98","author":"Tiribelli","year":"2019","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12920-019-0655-8","article-title":"Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis","volume":"13","author":"Zhang","year":"2020","journal-title":"BMC Med. Genomics"},{"issue":"11","key":"10.1016\/j.phrs.2020.104866_bib0345","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1161\/STROKEAHA.117.017681","article-title":"Bosutinib attenuates inflammation via inhibiting salt-inducible kinases in experimental model of intracerebral hemorrhage on mice","volume":"48","author":"Ma","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2020.104866_bib0350","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2015.07.070","article-title":"Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer\u2019s disease models","volume":"304","author":"Lonskaya","year":"2015","journal-title":"Neuroscience."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0355","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2017.74.7162","article-title":"Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: results from the randomized BFORE trial","volume":"36","author":"Cortes","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.phrs.2020.104866_bib0360","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2217\/fon-2018-0468","article-title":"Nilotinib in the treatment of chronic myeloid leukemia","volume":"15","author":"Sacha","year":"2019","journal-title":"Future Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbmt.2017.10.039","article-title":"Immunomodulatory effects of tyrosine kinase inhibitor in vitro and in vivo study","volume":"24","author":"Marinelli Busilacchi","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.phrs.2020.104866_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2020.01.014","article-title":"Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-\u03b2 and p-SMAD Pathway","author":"Marinelli Busilacchi","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0375","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2016.5","article-title":"Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial","volume":"30","author":"Hochhaus","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2020.104866_bib0380","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2019.10.036","article-title":"Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors","volume":"301","author":"Caocci","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104866_bib0385","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1002\/ajh.25102","article-title":"Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis","volume":"93","author":"Caocci","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"44","key":"10.1016\/j.phrs.2020.104866_bib0390","doi-asserted-by":"crossref","first-page":"72311","DOI":"10.18632\/oncotarget.11100","article-title":"Genetic predisposition and induced pro-inflammatory\/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients","volume":"7","author":"Bocchia","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0395","first-page":"1810","article-title":"Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia","volume":"91","author":"Gale","year":"1998","journal-title":"The German CML Study Group. Blood."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0400","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-018-0700-2","article-title":"Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?","volume":"41","author":"Hasselbalch","year":"2019","journal-title":"Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0405","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjh.14524","article-title":"How I manage patients with hairy cell leukaemia","volume":"177","author":"Thompson","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0410","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.15118","article-title":"Autologous stem cell transplant and combination immunotherapy of rituximab and interferon-\u03b1 induces prolonged clinical and molecular remissions in patients with follicular lymphoma","volume":"184","author":"Smyth","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0268-960X(97)90019-9","article-title":"Role of alpha interferon in multiple myeloma","volume":"11","author":"Joshua","year":"1997","journal-title":"Blood Rev."},{"issue":"9","key":"10.1016\/j.phrs.2020.104866_bib0420","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0425","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000057631","article-title":"Immune-mediated complications during interferon therapy in hematological patients","volume":"107","author":"Raanani","year":"2002","journal-title":"Acta Haematol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0430","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200653","article-title":"COVID-19 and emerging viral infections: the case for interferon lambda","volume":"217","author":"Prokunina-Olsson","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-019-1961-4","article-title":"Proteomic and histopathological characterisation of sicca subjects and primary Sj\u00f6gren\u2019s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers","volume":"21","author":"Cai","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0440","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3748\/wjg.v26.i5.478","article-title":"Shi RH. lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn\u2019s disease","volume":"26","author":"Li","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104866_bib0445","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3389\/fimmu.2019.01346","article-title":"Extracellular chromatin triggers release of soluble CEACAM8 upon activation of neutrophils","volume":"10","author":"Ribon","year":"2019","journal-title":"Front. Immunol."},{"issue":"1-2","key":"10.1016\/j.phrs.2020.104866_bib0450","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cellimm.2014.08.009","article-title":"Quantitative analysis of elastase and cathepsin G mRNA levels in peripheral blood CD14(+) cells from patients with rheumatoid arthritis","volume":"292","author":"Trzybulska","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.phrs.2020.104866_bib0455","first-page":"12","article-title":"Rapamycin protects chondrocytes against IL-18-induced apoptosis and ameliorates rat osteoarthritis","author":"Bao","year":"2020","journal-title":"Aging (Albany NY)."},{"key":"10.1016\/j.phrs.2020.104866_bib0460","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-981-15-1580-4_3","article-title":"CLEC5A: a promiscuous pattern recognition receptor to microbes and beyond","volume":"1204","author":"Sung","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2020.104866_bib0465","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"INDIA-FBP Group. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0470","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2020.104866_bib0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218323","article-title":"MiR-21 binding site SNP within ITGAM associated with psoriasis susceptibility in women","volume":"14","author":"Hruska","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0480","first-page":"352","article-title":"Regulation of PGLYRP1 and TREM-1 during progression and resolution of gingival inflammation","volume":"4","author":"Silbereisen","year":"2019","journal-title":"JDR Clin. Trans. Res."},{"issue":"20","key":"10.1016\/j.phrs.2020.104866_bib0485","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131355","article-title":"STAT6\/Arg1 promotes microglia\/macrophage efferocytosis and inflammation resolution in stroke mice","volume":"4","author":"Cai","year":"2019","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.phrs.2020.104866_bib0490","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98254","article-title":"Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2","volume":"4","author":"Brennan","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0495","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2006.08.026","article-title":"SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms","volume":"25","author":"Nagaishi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2020.104866_bib0500","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.12659\/MSM.911904","article-title":"Hypogelsolinemia in patients diagnosed with acute myeloid leukemia at initial stage of Sepsis","volume":"25","author":"W\u0105tek","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160511","article-title":"Host Nectin-1 promotes chlamydial infection in the female mouse genital tract, but is not required for infection in a novel male murine rectal infection model","volume":"11","author":"Slade","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.104866_bib0510","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.3389\/fimmu.2019.03087","article-title":"Kyburz D. miR-221-3p drives the shift of M2-Macrophages to a pro-inflammatory function by suppressing JAK3\/STAT3 activation","volume":"10","author":"Quero","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/10520295.2017.1278792","article-title":"Enhanced SOCS3 in osteoarthiritis may limit both proliferation and inflammation","volume":"92","author":"Gui","year":"2017","journal-title":"Biotech. Histochem."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12974-020-1700-4","article-title":"Pre-treatment with the viral Toll-like receptor 3 agonist poly(I:C) modulates innate immunity and protects neutropenic mice infected intracerebrally with Escherichia coli","volume":"17","author":"Ribes","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2020.104866_bib0525","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA119.001546","article-title":"The secretome profiling of a pediatric airway epithelium infected with hRSV identified aberrant apical\/basolateral trafficking and novel immune modulating (CXCL6, CXCL16, CSF3) and antiviral (CEACAM1) proteins","author":"Touzelet","year":"2020","journal-title":"Mol. Cell Proteomics"},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0530","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12696","article-title":"Hepatitis A virus cellular receptor 2 (HAVCR2) is decreased with viral infection and regulates pro-labour mediators OA","volume":"78","author":"Liong","year":"2017","journal-title":"Am J Reprod Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104866_bib0535","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jir.2018.0034","article-title":"Recombinant duck interferon gamma inhibits H5N1 influenza virus replication in vitro and in vivo","volume":"38","author":"Gao","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"issue":"7","key":"10.1016\/j.phrs.2020.104866_bib0540","doi-asserted-by":"crossref","first-page":"15442","DOI":"10.3390\/ijms160715442","article-title":"Eosinophil-derived neurotoxin (EDN\/RNase 2) and the mouse eosinophil-associated RNases (mEars): expanding roles in promoting host defense","volume":"16","author":"Rosenberg","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.104866_bib0545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.dci.2019.03.005","article-title":"The negative regulation of piscine CD44c in viral and bacterial infection","volume":"96","author":"Cao","year":"2019","journal-title":"Dev. Comp. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0550","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12967-019-02194-x","article-title":"Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-\u03b1","volume":"18","author":"Alves","year":"2020","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.phrs.2020.104866_bib0555","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.bbmt.2018.03.008","article-title":"Steroid refractory chronic graft-versus-Host disease: cost-effectiveness analysis","volume":"24","author":"Yalniz","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.phrs.2020.104866_bib0560","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.leukres.2018.10.002","article-title":"A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease","volume":"74","author":"Sweet","year":"2018","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0565","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4103\/1673-5374.266924","article-title":"Inflammation-related gene expression profiles of salivary extracellular vesicles in patients with head trauma","volume":"15","author":"Cheng","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104866_bib0570","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1139\/bcb-2016-0047","article-title":"Lactoferrin interacts with SPLUNC1 to attenuate lipopolysaccharide-induced inflammation of human nasal epithelial cells via down-regulated MEK1\/2-MAPK signaling","volume":"95","author":"Tsou","year":"2017","journal-title":"Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0575","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajog.2019.03.018","article-title":"Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes","volume":"221","author":"Yoon","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.phrs.2020.104866_bib0580","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2851949","article-title":"Triticum vulgare extract modulates protein-kinase B and matrix metalloproteinases 9 protein expression in BV-2 cells: bioactivity on inflammatory pathway associated with molecular mechanism wound healing","volume":"2020","author":"Funel","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.phrs.2020.104866_bib0585","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2018.01.004","article-title":"Its role for host defense, inflammation, and neutrophil function","volume":"640","author":"Myeloperoxidase","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2020.104866_bib0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2017.11.017","article-title":"Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages","volume":"15","author":"Lara-Guzm\u00e1n","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2020.104866_bib0595","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6941368","article-title":"Urokinase attenuates pulmonary thromboembolism in an animal model by inhibition of inflammatory response","volume":"2018","author":"Shi","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2020.104866_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.alit.2019.11.002","article-title":"Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings","author":"Yun","year":"2020","journal-title":"Allergol. Int."},{"issue":"6","key":"10.1016\/j.phrs.2020.104866_bib0605","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2016.02.029","article-title":"The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling","volume":"64","author":"Bottazzi","year":"2016","journal-title":"J. Hepatol."},{"issue":"50","key":"10.1016\/j.phrs.2020.104866_bib0610","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1038\/sj.onc.1210513","article-title":"Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation","volume":"26","author":"Kitisin","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0615","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/cdd.2016.108","article-title":"TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response","volume":"24","author":"Isaac","year":"2017","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.phrs.2020.104866_bib0620","first-page":"29","article-title":"TNFAIP8: inflammation, immunity and human diseases","volume":"1","author":"Niture","year":"2019","journal-title":"J. Mol. Cell. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104866_bib0625","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2020.03.009","article-title":"Immune sensing of synthetic, bacterial, and protozoan RNA by toll-like receptor 8 requires coordinated processing by RNase T2 and RNase 2","volume":"52","author":"Ostendorf","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.phrs.2020.104866_bib0630","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fneur.2020.00144","article-title":"Cognitive function in genetic generalized epilepsies: insights from neuropsychology and neuroimaging","volume":"11","author":"Ratcliffe","year":"2020","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104866_bib0635","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1933719115572484","article-title":"Adiposity alters genes important in inflammation and cell cycle division in human cumulus granulosa cell","volume":"22","author":"Merhi","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.phrs.2020.104866_bib0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109552","article-title":"Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity","volume":"69","author":"Krze\u015bniak","year":"2020","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.phrs.2020.104866_bib0645","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1194\/jlr.M067207","article-title":"CXCL3 positively regulates adipogenic differentiation","volume":"57","author":"Kusuyama","year":"2016","journal-title":"J. Lipid Res."},{"issue":"38","key":"10.1016\/j.phrs.2020.104866_bib0650","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/eurheartj\/ehy333","article-title":"Crucial role for Nox2 and sleep deprivation in aircraft noise-induced vascular and cerebral oxidative stress, inflammation, and gene regulation","volume":"39","author":"Kr\u00f6ller-Sch\u00f6n","year":"2018","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.phrs.2020.104866_bib0655","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nchembio.1105","article-title":"DAGL\u03b2 inhibition perturbs a lipid network involved in macrophage inflammatory responses","volume":"8","author":"Hsu","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0660","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10875-019-00702-8","article-title":"MiR-608 exerts anti-inflammatory effects by targeting ELANE in monocytes","volume":"40","author":"Gu","year":"2020","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0665","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/s41467-019-11058-3","article-title":"The nasal methylome as a biomarker of asthma and airway inflammation in children","volume":"10","author":"Cardenas","year":"2019","journal-title":"Nat. Commun."},{"issue":"38","key":"10.1016\/j.phrs.2020.104866_bib0670","doi-asserted-by":"crossref","first-page":"14839","DOI":"10.1074\/jbc.RA118.002907","article-title":"Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-\u03baB signaling in prostate cancer cells","volume":"293","author":"Wang","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2020.104866_bib0675","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00431-013-2047-y","article-title":"CD15s is a potential biomarker of serious bacterial infection in infants admitted to hospital","volume":"172","author":"Markic","year":"2013","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0680","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000131","article-title":"CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency","volume":"8","author":"Li","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0685","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jid.2018.02.027","article-title":"CCR4 is critically involved in skin allergic inflammation of BALB\/c mice","volume":"138","author":"Matsuo","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104866_bib0690","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000131","article-title":"CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency","volume":"8","author":"Li","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"6332","key":"10.1016\/j.phrs.2020.104866_bib0695","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science."},{"issue":"8","key":"10.1016\/j.phrs.2020.104866_bib0700","doi-asserted-by":"crossref","first-page":"12664","DOI":"10.18632\/oncotarget.8610","article-title":"CD74 and intratumoral immune response in breast cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"issue":"6372","key":"10.1016\/j.phrs.2020.104866_bib0705","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.aao1503","article-title":"CX3CR1+mononuclear phagocytes control immunity to intestinal fungi","volume":"359","author":"Leonardi","year":"2018","journal-title":"Science."},{"issue":"5","key":"10.1016\/j.phrs.2020.104866_bib0710","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"19","key":"10.1016\/j.phrs.2020.104866_bib0715","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194797","article-title":"Old players with new roles in iNKT cell development and function","volume":"20","author":"Bahal","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2020.104866_bib0720","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fimmu.2019.00184","article-title":"NFAT1 and NFAT2 differentially regulate CTL differentiation upon acute viral infection","volume":"10","author":"Xu","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104866_bib0725","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1189\/jlb.5A0516-240R","article-title":"Leukocyte phosphodiesterase expression after lipopolysaccharide and during sepsis and its relationship with HLA-DR expression","volume":"101","author":"Lelubre","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2020.104866_bib0730","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/icb.2017.59","article-title":"A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection","volume":"95","author":"Mangan","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"13","key":"10.1016\/j.phrs.2020.104866_bib0735","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/bph.14667","article-title":"Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:12:10Z","timestamp":1760911930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820311749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":147,"alternative-id":["S1043661820311749"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104866","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CoV-2 outbreak: how hematologists could help to fight Covid-19","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104866"}}